SCALING UP ART IN KENYA: Programmatic issues Mary Wangai MD Deputy Director National AIDS and STD Programme.

Slides:



Advertisements
Similar presentations
Group III: Demand Forecasting
Advertisements

Harmonization of donor reporting requirements for antiretrovirals and related drugs Presented at the WHO meeting, Geneva ( October 2005) Oteba Olowo.
An operational package for Integrated Management of HIV/AIDS prevention, treatment and care ICASA - Abuja, Nigeria 5 December 2005.
Priority Issues and Strategic Information Needs for Kenya in scaling up ART.
ART: The Basics William Aldis World Health Organization Bangkok, September 14, 2005.
MONITORING SYSTEM FOR THE ANTIRETROVIRAL THERAPY IN BRAZIL: LESSONS LEARNED AND FUTURE DIRECTIONS Marco Vitória, MD Brazilian STD/AIDS Programme - MOH.
Situation of HIV/AIDS services in Karamoja. Introduction 1M people infected with HIV. 110,000 children
Scaling up Prevention of Mother to Child Transmission of HIV (PMTCT): What Will it Take to Eliminate MTCT? Jessica Rodrigues Presentation for UNICEF Written.
Characteristics of clients undergoing repeat HIV counseling and testing compared to clients newly-tested for HIV in Nyanza Province Oyaro P, Owuor K, Ng’eno.
Ghana’s HIV Response The Ghana Team: Richard N. Amenyah Matilda Owusu-Ansah Evelyn Awittor Lord Dartey Mercy Bannerman.
Possible solution: Change testing & care for patients in TB treatment Old system TB patient treated at TB center Referred to VCT center for HIV testing.
Kevin Fenton, MD, PhD, FFPH Director, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention Centers for Disease Control and Prevention.
Health Indicators Population = 1.8 Million Annual growth rate = 1.9%. The life expectancy at birth = 41.2 The Infant Mortality Rate (IMR) 94/1000 HIV.
1 Care and Treatment Group 4 th Uganda AIDS Partnership Forum Munyonyo, 30 th Jan – 1 st Feb 06 Chair: Namuyomba Grace Secretary: Dr. Kyamanywa Dan.
LIMPOPO PROVINCIAL MEN’S SECTORS/BROTHERS FOR LIFE PRESENTED BY: RAPAKWANA JOHANNAH MANAGER:GAAP in HIV & AIDS & STIs Directorate DEPT OF HEALTH AND SOCIAL.
Involving the Community in HIV/AIDS Treatment Support Programmes: An Evidence-Based Approach.
Strategic Role in Advocacy. Church Health Services Coordination Committee (CHSCC) A Partnership Structure of CHAK, KEC and MEDS Appointed in line with.
Morbidity Monitoring Project Data for Resource Planning and Evaluation A.D. McNaghten Centers for Disease Control and Prevention.
Training course on Introducing pharmacovigilance into HIV/AIDS programmes Pretoria, South Africa, September 1-10,2004.
Monitoring Drug and Commodity Supply Chains for ARV Programmes Yasmin Chandani John Snow Inc/DELIVER.
Models of Care for Paediatric HIV Miriam Chipimo MD MPH Reproductive Health & HIV&AIDS Manager, UNICEF, Malawi.
Enabling Continuity of a Public Health ARV Treatment program in a resource limited setting: The Case of the transition of the African Comprehensive HIV/AIDS.
2013 WHO Consolidated ARV Guidelines Summary of Major Recommendations and Estimated Impact GSG Briefing July 19, 2013 Gottfried Hirnschall, Director HIV.
Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July
The U.S. President’s Emergency Plan for AIDS Relief 2011 Country Operational Plan Briefing to Development Partners in Health in Kenya December 3, 2011.
Pioneering IMAI: Developing an integrated approach in Uganda Dr Elizabeth Madraa, Program Manager National STD/AIDS Control Program MOH - UGANDA 5 th Dec.
Monitoring UA 2010 in health sector 1 |1 | Monitoring progress towards Universal Access 2010 in the health sector Kevin M De Cock Ties Boerma.
Downloaded from Current Status of ART Opportunities & Challenges Kibrebeal Melaku,MD Associate Professor.
Scaling up HIV Paediatric care Harvard – PEPFAR Program Chalamilla Guerino
Antiretroviral Pharmacovigilance Training Course Dar es Salaam, United Republic of Tanzania 23 rd – 28 th November 2009.
TB/HIV COLLABORATION IN GHANA Dr. Nii Nortey Hanson – Nortey National TB Control Programme Accra.
Provider initiated testing in Kenya Ruth Nduati Associate Prof Paediatrics University of Nairobi.
President’s Emergency Plan for AIDS Relief 2006 Semi-Annual Program Results (SAPR) October 1, 2005 – March 31, 2006.
Ensuring Access to Quality Voluntary Counseling and Testing services. Dr. Gloria Sangiwa. Family Health International
Report of the 2nd ad hoc Committee on the TB epidemic Jaap F. Broekmans STOP TB Partner’s Forum NEW DELHI June 2004.
Towards an effective eHealth in Kenya: Evolving role of Public Health Partnerships in the Tele-Health Revolution Steven Wanyee, MSc.
WORLD AIDS DAY Zero new HIV infections Zero discrimination Zero AIDS-related deaths.
Scaling-up HIV Prevention, Care and Antiretroviral Therapy at Primary Health Centers A WHO/PEPFAR Collaboration.
Antiretroviral treatment programme in Thyolo district, Malawi Southern Region. MSF Luxembourg & Thyolo District Health Services - Strategic information.
1 Scaling-up ARV Therapy in Vietnam HAIVN Harvard Medical School AIDS Initiative in Vietnam.
4 th AMTP UA Progress Report 5 th AMTP Outcomes Framework VISION The spread of HIV is halted in the Philippines OUTCOMES Persons at-risk, vulnerable,
United Republic of Tanzania Ministry of Health & Social Welfare MINISTRY OF HEALTH AND SOCIAL WELFARE NATIONAL AIDS CONTROL PROGRAM HIV CARE AND TREATMENT.
Main achievements and further developments 2006 and beyond: Overcoming HIV/AIDS epidemic in Ukraine (programme (programme supported by the Global Fund)
Overview of Capacity Building Programme for Uwezo Fund.
ARV Treatment Scale Up: Progress in Ukraine Andriy Klepikov Executive Director, International HIV/AIDS Alliance in Ukraine ARV Treatment Scale Up: Progress.
Gap Analysis: Tuberculosis Care in Malawi Round 11 proposal to the Global Fund to Fight AIDS, Tuberculosis and Malaria Africa 3: Team Malawi Arianna, Babatunde,
Prevention of Mother-to-Child Transmission of HIV: Scale-up of Critical Services in Uganda (District- based Approach) Edward Bitarakwate, MD, MPH Technical.
Compendium of Indicators for Monitoring and Evaluating National Tuberculosis Programs.
Strategic Information on ART Scale up Kevin O'Reilly Department of HIV/AIDS WHO.
Aids treatment on the field Experiences from CAMEROON Swiss AIDS platform Aidsfocus Bern, April 2004 Béata UMUBYEYI.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
From choice, a world of possibilities ART Delivery: Providing ART in Sexual and Reproductive Health Setting A Presentation of the Work of Family Health.
HIV/AIDS Epidemic in India Trends, Lessons, Challenges & Opportunities
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Number of people receiving antiretroviral therapy in
HIV and AIDS The management of HIV and AIDS is an ongoing challenge for Anglo companies operating in countries with a high burden of HIV disease Strategy.
THE HEALTH SECTOR RESPONSE TO THE HIV/AIDS EPIDEMIC
Expanding ARV treatment in developing countries: Issues and Prospects
Using CBR Guidelines as an integrated Approach to Development
Madisa Mine National Health Laboratory Gaborone, BOTSWANA
"3 by 5" progress December 2005.
Education in Emergencies Working Group
WHO 2015 GUIDELINES AND FAST TRACKING TOWARDS : Regional perspective
Managing Procurement and Logistics of HIV/AIDS Drugs and Related Supplies Introduction and Overview May 30 to June 4, 2005 Abuja, Nigeria.
Patrick Brenny, UNAIDS RST-WCA
China 2010 UNGASS Country Progress Report
Access to HIV/AIDS Medicines The 3x5 strategy
Dr. Kenneth L. Chebet Director NASCOP/NLTP Division Kenya
Collaborative TB/HIV activities in European Region
Contents Global impact 2.Service cascade 3. Policies and WHO support.
Presentation transcript:

SCALING UP ART IN KENYA: Programmatic issues Mary Wangai MD Deputy Director National AIDS and STD Programme

Introduction 2.2 m Kenyans estimated to be HIV+ and 200, 000 needing antiretroviral therapy (ART) Negative impact on all sectors of society Reversed previous health gains: life expectancy 62 to 46 years 50% to 70% of hospital bed occupancy at medical wards in many government hospitals are HIV related Increased death rate: Est. 500 deaths daily

National estimate summary Significant drop in national HIV prevalence in the last 3 years: 13 to 10% The country experienced high infection rates in the mid 90’s culminating in peak prevalence in 1998, 1999, Initially the prevalence among the young was higher than the older age group but now it is lower or equal in almost all the sites and in the national statistics.

HIV Prevalence in Pregnant Women in Sentinel Surveillance Sites in Kenya

HIV Prevalence by Age Group

Trends in mortality among children under five years old,

Working Programme Goal “Progressively deliver effective ART, reaching 20% by 2005 and 50 – 60% by 2008, so as to increase quality of life and survival by 10 years; reduce HIV-related hospital admissions by 60% and enhance significantly national prevention efforts”

GOK Policy HIV/AIDS Control is top priority for current government Funds committed in 2002/3 budget Lab capacity for monitoring patients Assuring drug quality Seed money to purchase ARVs for regional sites Parallel importation of brand and generic drugs Commitment to private-public sector partnership Ensure quality, standard care and access Recognition that ARVs are essential drugs Cost sharing/recovery in the public sector

Program gains Guidelines on ARV use, OI prophylaxis, home based care and VCT are available Standard regimen determined National 1 st and 2 nd line ART ARV training of health workers is ongoing Branded and generics ARVs are available Costs are falling, due to increasing access – generic 1 st line cost US$ 35 to $40 /month

National ART regimens Adults: 1 st line: Stavudine + Lamivudine + Nevirapine/Efavirenz 2 nd Line: Zidovudine + Didanosine + Nelfinavir/Kaletra(Lopinavir/Ritonavir) Children: Zidovudine + Lamivudine + Nevirapine

NASCOP Situational Assessment Assessment covered: National Central Management Unit and ART in Kenya generally ( Nov to Dec 2002) 13 sites using JSI modified instrument (May 2003): 7 Provincial Hospitals 4 High volume Districts 2 Teaching Hospitals

Current anti-retroviral therapy ART Activities Est. 7 to 9,000 patients are on ART in Kenya. ART available at ~ 20 private companies, numerous private physicians and hospitals 34 / 57 mission hospitals, increased from 600 to 2400 patients in 1 year 5 public health facilities in collaboration with partners; 1500 patients 2 NGO health facilities; 50 patients

Public Sector and partners Currently providing ART Homabay MSF-F Eldoret MOI Nairobi CDC Amref MSF -B Nakuru MOH Mombasa FHI GOK Partners

Faith based Hospitals Currently providing ART Kiambu-3 Thika Nyeri-2 Nyandarua Machakos Meru-2 Meru-N Meru-S Nairobi-4 Kisumu-2 Nyando Rachuonyo Trans Mara Bomet Kakamega Butere Bungoma

Issues for Scaling up Public and private sector partnership Private sector target those who can pay Public sector target this with limited ability Systems concerns Trained personnel Procurement & Logistics Data management Infrastructure Quality assurance and Quality Control M& E : HMIS and patient tracking system

Scale up ART Homabay MSF Eldoret MOI Nairobi CDC/ Amref MSH-F Nakuru MOH Mombasa FHI GOK Partners Mombasa General Kenyatta N.Hosp New Nyanza Hosp Thika Garissa Embu Nyeri Machakos Kakamega Mbagathi Busia Kitale Kisii Kilifi

GOK to support 5-6 Faith based Hosp CHAK Nazareth Maua Tenwek MEWA Tabaka Kendu-bay Catholic CHAK Muslim CHAK

Challenges Inadequate funds and system related weaknesses Physical infrastructure at health facilities Policy gaps e.g. equity, waiver system Human resources- numbers, training and cadre Quality control and assurance mechanisms Home Based Care Facilities-inadequate

Way Forward Policy Formulation Human resources assessment, planning and training. Strategic plan formulation Operational planning exercise – upscale to 13 sites by January To include communication strategy, LMIS, M&E Framework, Adherence Strategy